$7.68
3.50%
NYSE, Sep 02, 10:12 pm CET
ISIN
CA0717341071
Symbol
BHC

Bausch Health Companies Inc. Stock price

$7.68
+1.90 32.87% 1M
+0.51 7.11% 6M
-0.38 4.71% YTD
+1.75 29.51% 1Y
+1.23 19.07% 3Y
-8.71 53.14% 5Y
-224.50 96.69% 10Y
-9.19 54.47% 20Y
NYSE, Closing price Tue, Sep 02 2025
+0.26 3.50%
ISIN
CA0717341071
Symbol
BHC
Industry

Key metrics

Basic
Market capitalization
$2.7b
Enterprise Value
$22.7b
Net debt
$20.0b
Cash
$1.7b
Shares outstanding
369.8m
Valuation (TTM | estimate)
P/E
29.5 | 1.9
P/S
0.3 | 0.3
EV/Sales
2.3 | 2.2
EV/FCF
20.6
P/B
negative
Financial Health
Equity Ratio
-4.8%
Return on Equity
3.6%
ROCE
8.5%
ROIC
1.3%
Debt/Equity
-28.5
Financials (TTM | estimate)
Revenue
$9.9b | $10.2b
EBITDA
$2.9b | $3.5b
EBIT
$1.9b | $3.2b
Net Income
$98.0m | $1.5b
Free Cash Flow
$1.1b
Growth (TTM | estimate)
Revenue
7.1% | 6.3%
EBITDA
4.9% | 19.6%
EBIT
10.0% | 75.0%
Net Income
120.8% | 3,282.4%
Free Cash Flow
21.2%
Margin (TTM | estimate)
Gross
70.7%
EBITDA
29.7% | 34.3%
EBIT
19.1%
Net
1.0% | 14.3%
Free Cash Flow
11.2%
More
EPS
$0.3
FCF per Share
$3.0
Short interest
2.4%
Employees
21k
Rev per Employee
$460.0k
Show more

Is Bausch Health Companies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Bausch Health Companies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Bausch Health Companies Inc. forecast:

5x Hold
56%
4x Sell
44%

Analyst Opinions

9 Analysts have issued a Bausch Health Companies Inc. forecast:

Hold
56%
Sell
44%

Financial data from Bausch Health Companies Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
9,858 9,858
7% 7%
100%
- Direct Costs 2,888 2,888
7% 7%
29%
6,970 6,970
7% 7%
71%
- Selling and Administrative Expenses 3,431 3,431
10% 10%
35%
- Research and Development Expense 611 611
0% 0%
6%
2,931 2,931
5% 5%
30%
- Depreciation and Amortization 1,045 1,045
3% 3%
11%
EBIT (Operating Income) EBIT 1,886 1,886
10% 10%
19%
Net Profit 98 98
121% 121%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Bausch Health Companies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bausch Health Companies Inc. Stock News

Neutral
Accesswire
8 days ago
LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) today announced that BHC Lyon Merger Sub, Inc. ("Purchaser"), a wholly owned subsidiary of Bausch Health Americas, Inc. ("BHA"), and an indirect subsidiary of Bausch Health Companies Inc. ("BHC"), h...
Neutral
Accesswire
13 days ago
LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced that PrCABTREO™ (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, for the treatment of acne vulgaris,1 is now available to beneficiaries of the public drug p...
Neutral
Reuters
15 days ago
Bausch + Lomb said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire Carl Icahn and some of his affiliates.
More Bausch Health Companies Inc. News

Company Profile

Manufactures and markets pharmaceutical products

Head office Canada
CEO Thomas Appio
Employees 20,700
Founded 1994
Website www.bauschhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today